Clinical trial · Observational
Association of CD49d and CD44 in CLL Patients and Their Role in Prognosis
NCT03380299CI-TRIAL-00030869unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The interactions of chronic lymphocytic leukemia cells with the microenvironment in secondary lymphoid tissues and the bone marrow are known to promote CLL cell survival and proliferation
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cellular Diagnosis, Chronic Lymphocytic Leukemia | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To what extent the identification of molecular and biological prognostic markers has provided new insights into the risk stratification of patients with CLL .
- timeFrame
- 1 YEAR
- description
- detecting membrane expression of CD49d and CD 44 and thier role in prognosis of CLL patients.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * All patients are newly diagnosed as CLL Exclusion Criteria: * : patients with associated malignancies
References
Publications (0)
Data not yet available
No reference posted for this study.